TrialSignal transduction and targeted therapy2026
Sirolimus plus roxadustat synergistically enhances immunosuppression and erythropoiesis in pure red cell aplasia: a multicenter trial.
Hong Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.